HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Todd Grinnell Selected Research

eslicarbazepine acetate

1/2021Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD.
1/2021Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs.
1/2021Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
12/2020Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses.
11/2020Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial results.
11/2020Long-term safety and tolerability of adjunctive eslicarbazepine acetate in children with focal seizures.
5/2020Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate.
1/2020Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures.
1/2019Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
1/2019Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Todd Grinnell Research Topics

Disease

18Seizures (Absence Seizure)
01/2021 - 03/2015
4Epilepsy (Aura)
01/2021 - 01/2019
2Hyponatremia
01/2019 - 01/2018
2Dizziness (Lightheadedness)
11/2018 - 01/2018
2Headache (Headaches)
11/2018 - 01/2018
1Hypersensitivity (Allergy)
05/2020
1Diplopia (Double Vision)
11/2018
1Vertigo (Positional Vertigo)
11/2018
1Vomiting
11/2018
1Nausea
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
06/2012

Drug/Important Bio-Agent (IBA)

16eslicarbazepine acetateIBA
01/2021 - 03/2015
7Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 03/2015
2Pharmaceutical PreparationsIBA
01/2021 - 06/2012
2Lamotrigine (Lamictal)FDA LinkGeneric
12/2020 - 11/2018
2SodiumIBA
01/2019 - 01/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 01/2017
1brivaracetamIBA
01/2021
1Sodium Channels (Sodium Channel)IBA
12/2020
1Levetiracetam (Keppra)FDA LinkGeneric
12/2020
1Carbamazepine (Tegretol)FDA LinkGeneric
11/2018
1Voltage-Gated Sodium Channel BlockersIBA
11/2018
1LipidsIBA
01/2018
1EnzymesIBA
01/2018
1eslicarbazepineIBA
01/2018
1Rosuvastatin Calcium (Crestor)FDA Link
01/2017
1Eszopiclone (Lunesta)FDA Link
06/2012

Therapy/Procedure

7Therapeutics
01/2021 - 01/2018